Asthma Imaging

No Results

No Results

processing….

Chest radiographic imaging (see the images below) is an important tool in the examination of patients with an exacerbation of asthma, but patients should not be left waiting in the treatment room for a radiograph before treatment. ^[1] Chest radiography is the initial imaging evaluation in most individuals with symptoms of asthma. The value of chest radiography is in revealing complications or alternative causes of wheezing and the minor importance of wheezing in the diagnosis of asthma and its exacerbations. It usually is more useful in the initial diagnosis of bronchial asthma than in the detection of exacerbations, although it is valuable in excluding complications such as pneumonia and asthma mimics, even during exacerbations. ^{[2, 3]}

Although bronchial thickening, hyperinflation, and focal atelectasis suggest asthma when they are present, chest radiographs obtained during asthma exacerbations can demonstrate normal findings, which reduce its sensitivity as a diagnostic tool. Similarly, identical findings may be observed with chronic bronchitis and viral bronchopneumonia, among other conditions, and these similarities limit the specificity of chest radiography. Clinical correlation remains beneficial in the interpretation of findings, as it is in so many other areas of radiology.

High-resolution computed tomography (HRCT) is a second-line examination (see the images below). It is useful in patients with chronic or recurring symptoms and in those with possible complications such as allergic bronchopulmonary aspergillosis and bronchiectasis. ^[4]

HRCT is more costly than chest radiography and exposes the patient to more radiation. Nevertheless, CT scans can demonstrate a number of findings that support the diagnosis of asthma. HRCT remains the most sensitive study for morphologic changes associated with asthma. HRCT has the potential to aid with the functional assessment of the lungs, such as tests of airtrapping and the bronchodilator response. The specificity of HRCT for bronchial asthma is limited by the similarity of its changes to those of other diseases, such as bronchiectasis, chronic bronchitis, emphysema, and bronchopulmonary aspergillosis.

The aphorism attributed to Chevallier Jackson states, “All that wheezes is not asthma.” This recognition suggests that imaging has an important role in differentiating asthma from its mimics and that further diagnostic evaluation and treatment of nonasthma conditions may be necessary. With his or her knowledge of the imaging findings in alternative disorders, the consulting radiologist may be valuable during the workup; he or she can recognize clinical signs and symptoms that indicate the use of high-resolution chest CT, sinus CT, CT pulmonary angiography, or MRI as the best modality for further imaging in the diagnosis.

Various tracheal tumors, foreign bodies, and other conditions can contribute to wheezing. These may be misdiagnosed for several years before they are recognized.

Diffuse panbronchiolitis is prevalent in Japan and the Far East, and it may mimic bronchial asthma with wheezing, coughing, dyspnea on exertion, and sinusitis. ^[5] HRCT findings include centrilobular nodules and linear markings that usually are more profuse compared with the multifocal bronchiolar impaction sometimes observed with asthma.

Sinus disease, especially in children, is associated with bronchial asthma and wheezing. Although the association is not strong in patients with CT evidence of mild sinus mucosal thickening, a scoring system developed by Newman et al showed that extensive sinus disease was correlated with a substantially higher extent of wheezing than that in patients with only mild thickening. ^[6] Of 104 adults, 39% had extensive disease, as visualized on CT scans, which was correlated with asthma and peripheral eosinophilia.

In a Finnish study of hospital admissions for acute asthma, admission chest radiographs showed abnormalities in 50% of the patients and resulted in treatment changes in 5%. The numbers were more remarkable when a paranasal sinus series was obtained in unselected patients presented primarily because of asthma. A sinus abnormality of any kind was found in 85% of patients; maxillary sinus abnormalities occurred alone in 63%. In 29% of patients with a sinus abnormality, treatment was immediately altered. All abnormalities were identified on the Waters view alone, which is 6 times more useful than the Chest radiography in directing the treatment of acute asthma. ^[7] Although the findings are provocative and require confirmation, the conventional wisdom regarding the sinus radiographic evaluation of chronic coughing and asthma suggests that a workup for chronic coughing should be performed first. ^[8]

Cough, recurrent bronchitis, pneumonia, wheezing, and asthma are associated with gastroesophageal reflux (GER). ^{[9, 10]} The incidence of GER in those with asthma ranges from 38% in patients with only asthma symptoms to 48% in patients with recurrent pneumonia. Scintigraphic studies performed after technetium-99m sulfur-colloid ingestion have shown radionuclide activity in the lungs the next day, but no causal relationship between reflux and asthma has been established. Nevertheless, evidence suggests that increased pulmonary resistance occurs with symptoms of reflux during acid provocation testing; as some have suggested, the changes may be sufficiently significant to produce clinically evident bronchospasm. ^[9]

Pneumothorax may be evident radiographically before it is identified clinically. ^[11] It often occurs during recurrent episodes of bronchospasm, as well as in other conditions. The presence of an air-fluid level in a hydropneumothorax can be confused with pneumatocele, infected cysts, and cavitary lung disease.

For patient education information, see the Asthma Center, as well as Asthma and Asthma in Children.

In most patients with uncomplicated asthma, radiographic findings are normal. In patients with more advanced asthma, varying stages of hyperinflation are reflected on chest radiographs by a flattening of the hemidiaphragm, increased retrosternal airspace, and relatively minor differences in diaphragmatic positions between inspiration and expiration. Other features of bronchial asthma include a mild prominence of the hilar vasculature that results from transient pulmonary hypertension and mucous plugging with or without atelectasis. ^[12]

See the chest radiographic images below.

In early studies, lung opacity on chest radiography was evaluated in 8 regions in patients with asthma; the findings recapitulated the heterogeneous distribution of localized airtrapping seen on radioactive noble gas scintigrams obtained a decade earlier. ^[13] Airtrapping increases the TLC and FRC and reduces the vital capacity (VC) and inspiratory capacity (IC), where IC = TLC – FRC.

FRC, which is the lung volume remaining at the end of expiration, also remains high in the patient with symptomatic asthma; this observation reflects the patient’s inability to breathe out in the setting of obstructing secretions, airway narrowing, and edema.

Traditionally, the FRC and TLC have been measured in the pulmonary function laboratory, and planimetry was used in the past to assess the radiographic equivalent of the TLC. A planimeter is a mechanical device used with inspiratory posteroanterior (PA) and lateral CXRs. Formulas are used to calculate the lung volume by using a series of virtual sections in which airspace cross-sectional areas are quantified. This procedure was established as a means of diagnosing hyperinflation in bronchial asthma when correlation coefficients of 0.94 were found for helium dilution lung volumes and body plethysmography. A decrease in the TLC after treatment for asthma can be correlated with patient improvement, even when the FEV1 does not improve; this effect likely is related to an improvement in IC. ^[14]

The reliability of planimetry in the diagnosis of asthma in children also was established. ^[15] Findings from a more recent study casts doubt on the usefulness of planimetry in patients with occupational asthma. ^[16]

The direct measurement of airway wall thickness with chest radiographs was undertaken in patients with mild and severe asthma and in individuals without asthma. ^[17] The ratio of the internal luminal diameter to the wall thickness was determined by optically measuring the bronchi, as viewed end-on on radiographs, and by reviewing plain radiographic tomograms. The measurements were compared by means of subjective assessment alone. In 11 of 15 patients with severe asthma, subjective assessment results matched the measurements.

The authors stated that the finding of more than 2 measurably thickened bronchial walls was rare in individuals without asthma; however, in patients with more severe asthma, the margins of the bronchial walls were delineated better and distinguishable from the findings in individuals without asthma. Ratios varied with bronchiolar luminal diameter, and the authors believed that the ratio was more an index of chronicity than an index of severity.

Nonsegmental, widespread, streaky opacities likely represent focal linear atelectasis resulting from viral superinfection. ^[18] Segmental opacities may represent localized poor airway mucociliary clearance with atelectasis or early consolidation.

Radiographic correlates of increased TLC that result from airtrapping and small bronchiolar obstruction include hyperinflation; low diaphragms; and, in children, sternal bowing. Sternal bowing reportedly is present in children when the hemidiaphragms are below the 9th or 10th posterior ribs or when the dome of the diaphragm is below the 6th mid anterior rib interspace. ^[18] However, the value of these findings as an index of severity is disputed. ^[19] Hemidiaphragms may be flat or inverted, as in tension pneumothorax, and the lateral slips of the diaphragm may be observed, especially on CT scans.

Recently, observers of 65 children hospitalized for asthma noted the inversion of the pulmonary venous distribution that is typically observed in individuals with left heart failure. ^[20] The children tended to be younger (6.75 y vs a group mean of 9.2 y), and they had tachypnea, retractions, nasal flaring, and tachycardia. The proposed mechanism was increased intrathoracic pressure that led to right ventricular overload, paradoxical septal motion with loss of left ventricular compliance, and elevated left atrial and pulmonary venous pressures. To the authors’ knowledge, this finding has not been replicated since that study, but it remains an interesting observation.

Several studies have been performed to evaluate the clinical usefulness of chest radiography. ^{[21, 22, 23, 24, 18, 25, 26, 27, 28, 27, 29, 30, 31, 32, 33]}

In a study of 117 patients with asthma who were older than 15 years, hyperinflation and bronchovascular changes were seen on chest radiograph in 31% of patients in whom asthma began before they were aged 15 years. However, these changes were not observed in any patients in whom asthma began after they were aged 30 years. ^[21]

In a study of outpatients with acute asthma who present to an emergency department (ED), a mean of 55% of patients had normal radiographic findings, while 37% had findings of hyperinflation, and 7% had minimal and unchanged interstitial abnormalities. ^[22] Pneumonia was present in 16% of adults. Despite the large statistical range of patients with only normal findings (30-81%) and despite the discovery of pneumomediastinum in 5% of children, the authors concluded that chest radiography was not helpful unless complications of asthma were suggested clinically.

One of the largest studies of ED visits involving CXRs was performed in a large city hospital. In this study, findings in 5,000 patients were reviewed; 2-view radiographs used in two thirds of the patients and only portable radiographs were used in one third. Overall, 35% of the patients with chest symptoms had serious radiographic findings, but only 14% of the patients with symptoms of asthma had serious radiographic abnormalities. However, the applicability of these findings to individual CXR findings of asthma is limited by the small proportion of total radiographs (4.6%) obtained in patients with asthma. ^[26]

In a British general hospital ED, findings in 695 episodes of acute asthma in adults and children were evaluated. CXRs were obtained in 135 of 695 patients, or 19% of the total instances of asthmatic exacerbation. Of the radiographs, 79% (presumably portable radiographs) demonstrated normal findings. Abnormalities included evidence of infection (13%), hyperinflation (7%), and edema (2%). Increased perihilar markings were observed in only 2 patients. ^[30]

In an early study, the value of routine admission radiography in adults with asthma was evaluated in regard to the presence of pneumonia in patients with acute respiratory complaints. Among patients with asthma, only 2% had concurrent pneumonia. ^[25] .

Sherman et al examined patients with exacerbations of chronic obstructive airway disease (COPD). More than half of the 242 hospitalized patients had a “predominant clinical pattern of asthma.” Wheezing was not specifically listed as a clinical finding for any patient, although cough and dyspnea were included. Only 4.5% of the radiographs resulted in clinically significant findings that changed the treatment planned with clinical and laboratory criteria alone, in the asthma group as well as the whole group.

Sherman et al ^[28] concluded that admission chest radiography is justified only after the following selection criteria are met: WBC more than 15 X 10⁹/L; polymorphonuclear count more than 8 X 10⁹/L; or a history of congestive heart failure, coronary artery disease, chest pain, or edema. The findings affirmed the observation that chronic bronchitis and emphysema can have a presentation similar to that of bronchial asthma. This result is notable because it came in one of the earlier studies that did not find value with routine CXR in the ED for patients with asthma.

In a blinded retrospective review, the effect of chest radiography on clinical decision making, including those related to hospital admission, was evaluated in a busy large-city ED. ^{[27, 32]} Criteria for complicated airway disease included COPD, fever, heart disease, intravenous drug abuse, immunodeficiency, and/or prior thoracic surgery but not diabetes or steroid use. Of the 27 patients in whom treatment was altered, 96% had clinically and radiographically complicated cases. Abnormal radiographic features that were influential in the clinical input included infiltrate in 63%, congestive heart failure in 26%, and lobar collapse in 4%. Features of uncomplicated CXRs were peribronchial thickening in 18% and atelectasis and other findings in fewer than 10%. Had the stated criteria for complicated asthma versus uncomplicated asthma been applied, chest radiographic examinations for hospital admission would have decreased by an estimated 34%.

In another study, more than 85% of patients underwent 2-view radiographs; in earlier studies, a lower proportion of PA and lateral examinations were performed relative to portable anteroposterior (AP) studies. ^[28]

White et al prospectively studied admission chest radiographs in a large-city ED. PA and lateral radiographs were obtained in more than 95% of the patients who eventually were admitted after a 12-hour course of treatment. Major findings, present in 34% of the patients, included focal opacity, increased interstitial markings, cardiomegaly, pulmonary venous congestion, pneumothorax, and new pulmonary nodules. Minor findings, present in 41%, included hyperinflation, pleural thickening, and calcified granulomas. Focal opacities or increased interstitial markings were correlated with subsequent antibiotic use, independent of an elevated WBC or body temperature. The authors concluded that CXRs should be obtained in all adult patients with acute asthma who are admitted. ^[29]

In children, the natural overlap of nonbacterial bronchiolitis with bronchial asthma accounts for their similar findings on radiographs. Findings of an increased retrosternal airspace and flattened hemidiaphragms sometimes are accompanied by peripheral arterial attenuation. These findings are components of the hyperinflation observed with both entities. ^[34]

A study of 371 children with first-time wheezing led to the establishment of criteria for obtaining chest radiographs. ^[24] The criteria include a heart rate higher than 160 bpm or a respiratory rate higher than 60 per minute, localized rales or localized decreased breath sounds before treatment, and/or persistent localized rales and localized wheezing after treatment. Patients are more likely to have significantly positive chest radiographic findings when criteria are met. Of children with abnormal radiographic findings of segmental atelectasis, pneumonia, and pneumomediastinum, 95% met the prospective criteria. However, negative findings still included hyperinflation, thickened airways, peribronchial thickening, and subsegmental atelectasis.

Roback et al also evaluated the use of chest radiography in children with first-time wheezing by using the practice parameters of Gershel et al as a yardstick with which to compare actual clinical practice. The retrospective study revealed that, of the 41% of the patients who underwent chest radiography, 24% had a clinically significant abnormality such as local consolidation, pneumothorax, pneumomediastinum, asymmetric opacity, hyperinflation, segmental atelectasis, edema, cardiomegaly, or airway compression. ^[33]

In the study of Roback et al, ^[33] an elevated temperature (mean, 37.9°C), absence of a family history of asthma, localized wheezes, decreased breath sounds, and rales significantly predicted the decision to perform chest radiography. Patients in whom chest radiography was performed (67%) were more likely to have positive findings when they had a slightly elevated temperature, a family history of asthma, or localized wheezes or rales. Of patients in whom chest radiography was not performed, 62% would have undergone radiography with the criteria of Gershel et al. Of patients who underwent radiography, 74% did not meet these criteria; this finding suggests that the criteria and actual clinical practice widely differ.

A more recent study of pediatric asthma examined children with first-time wheezing who presented to the ED in a large-city children’s hospital. On the radiographs obtained in these children, 61% showed findings of uncomplicated bronchiolitis or asthma (hyperinflation in 85%, peribronchial cuffing in 68%, interstitial or perihilar opacities in 31%, and atelectasis), and 18% showed parenchymal opacities (lobar or segmental). Only 21% of patients had completely normal radiographic findings.

Rubenstein et al ^[31] compared the usefulness of routine spirometry with that of chest radiography in patients with mild ambulatory asthma in a university student population. Although 36% of the patients had spirometric results consistent with airway obstruction (predicted FEV1 < 80%, predicted peak expiratory flow rate [PEFR] < 85%, or 20% improvement with bronchodilators), 59% had abnormal radiographic findings consisting of hyperinflation, increased perihilar markings, and peribronchial or peribronchiolar cuffing. Bronchitis and/or bronchiolitis and bronchial asthma caused the radiographic findings. Thus, although chest radiography lacks optimal specificity, it may be valuable in the diagnosis of bronchial asthma when the clinical features were taken into account.

Bronchography is a technique, now largely archaic, that is used to visualize the trachea and large airways by instilling a radiopaque, oily emulsion into the airways via an airway catheter or bronchoscope. For many years bronchography, was a criterion standard in the detection of bronchiectasis, but bronchography was known to induce transient bronchospasm and impair ventilation and diffusion capacity, especially in individuals with asthma. Typically, bronchography was considered contraindicated in severe reactive airway disease, although it was useful in the examination of individuals with milder asthma with suspected bronchiectasis. ^[35]

A group from Finland used cinetracheobronchography to visualize the main airways in individuals with asthma. The investigators introduced bronchography contrast enhancement and performed radiography during the patient’s quiet breathing, forced expiration, and coughing. ^[36] The authors described findings in a patient in whom complete closure of the distal trachea during coughing was associated with both cartilaginous and membranous weakening. The patient’s condition responded to endobronchial prosthesis with a marked improvement in airflow and symptoms.

In dogs, tantalum bronchography was performed in studies of experimental asthma at the Cardiovascular Research Institute during the 1960s and 1970s. Tantalum fine powder was insufflated into the bronchi, and it allowed detailed study of airways in asthma caused by various pharmacologic agents with and without bronchial provocation by allergens and particulates.

In one study, nematode antigen caused airway narrowing of differing degrees, according to airway size. Airways sized 1- to 8-mm had the greatest diameter decrease (49%) compared with airways with diameters greater than 12 mm, 8-12 mm, or 0.5-1.0 mm. Although it is not entirely inert, the stimulation of increased respiratory system resistance by the antigen is controlled by the dose. ^[37]

Nematode antigen was used to evaluate airway narrowing in some patients with asthma. The advantage of the metallic powder is its relatively inert character in the airways, although it is known to affect mucociliary clearance to a small degree. ^[38] The agent was used to study the somewhat twitchy airways of patients with asthma, in contrast to the more noxious, typical, oil-based, iodinated suspensions that are commonly used for bronchography.

The role of computed tomography (CT) in the imaging of airway disease increased after the development of lung high-resolution CT (HRCT). The technical progress of thin-section acquisition, high-spatial-frequency data reconstruction (ie, bone algorithm technique), and targeted reconstruction has allowed the visualization of finer details on HRCT scans; these details include airtrapping, measurable bronchial wall thickening, atelectasis, centrilobular nodules due to mucous plugging, and acinar nodules due to low-grade inflammatory changes. ^{[39, 40, 41]}

King et al discuss details of HRCT methods for evaluating the airways in obstructive pulmonary disease. ^[42] They discuss the technical features of HRCT and review its use in the assessment of obstructive airway disease.

See the asthma-related HRCT images below.

In one study, the intact lobes of pressurized canine lungs were evaluated with HRCT before and after the administration of carbachol, a bronchoconstrictor. Intermediate-sized airways had the most prominent decreases in luminal area; 2- to 4-mm airways had a 56% reduction in diameter, and 4- to 6-mm airways had a 59% reduction. Wall thickening was believed to result, in part, from increased bronchial blood flow, edema, and smooth muscle hyperplasia. The lower range of visibility was at the generally accepted maximal diameter of small airways, that is, 2 mm. ^[43]

Herold et al established the usefulness of HRCT in measuring the bronchial response to bronchoconstrictors in the setting of hyperreactivity. Responses to aerosol isotonic sodium chloride solution and histamine were assessed in anesthetized ventilated dogs and corrected for lung volume. Airway cross-sectional area decreased by 43% after histamine administration and by 26% after saline administration alone, but intersubject and intrasubject variability was significant; the irritant effect of the base aerosol was evident. Although airways as small as 1 mm were evaluated, the discrepancy between the response of large airways (ie, bronchoconstriction) and small airways (ie, change in mean airway pressure) could not be explained. ^[44]

The role of vascular engorgement and edema was evaluated with HRCT. Dogs received 3 successive 50 mL/kg isotonic sodium chloride challenges or 2 successive 25 mL/kg blood infusions. This large sodium chloride load caused more airway wall thickening and luminal narrowing than blood alone. With sodium chloride, the luminal area and wall thickness were 68% and 150% of those at baseline, respectively; with blood, the results were 81% and 108% of those of baseline, respectively. The findings were not reversible within 30 minutes. Also, the findings were attributed to edema in airway walls, but they were considered to have only a minor role in the multiple causes of increased airway resistance in asthma and left ventricular dysfunction. ^[45] .

The investigators then showed that, although the initial histamine challenge narrowed the airways to 71% of their baseline luminal area, the sodium chloride challenge alone (100 mL/kg) reduced the airway lumen to 78% of its baseline size. Potentiation of the effect by combining sodium chloride and histamine reduced the luminal area to 54% of its baseline value. These findings were correlated with the known exaggerated constrictor response to provocation in the setting of airway edema ^[46] .

Findings from later studies of the role of inflammatory mediators in airway hyperresponsiveness led to the conclusion that methacholine and bradykinin, alone or combined, have only minor effects on bronchoconstriction ^[47]

HRCT findings in bronchial asthma include the following:

Bronchial wall thickening

Bronchial dilatation

Cylindrical and varicose bronchiectasis

Reduced airway luminal area

Mucoid impaction of the bronchi

Centrilobular opacities, or bronchiolar impaction

Linear opacities

Airtrapping, as demonstrated or exacerbated with expiration

Mosaic lung attenuation, or focal and regional areas of decreased perfusions

Some initial human studies involved emphysema scoring in patients with asthma. Royle first described emphysema in severe asthma by using radiographs in current or former smokers.

In the late 1980s, a group evaluated the coexistence of emphysema and asthma findings using HRCT. In comparing 10 nonsmoking patients with asthma with 10 matched cigarette smokers with severe airflow obstruction, an emphysema grade of 0% was observed in the nonsmokers, and 100%, in smokers; the emphysema score reflected vascular disruption, bullae, and low-attenuating areas. Although all smokers with a TLC greater than 120% had at least some emphysema, no nonsmoking patients with asthma had emphysema. The authors concluded that, in patients with asthma, elevated TLC between attacks can be explained by hyperinflation, which is entirely due to asthma and not coexisting emphysema. ^[48]

Paganin et al studied airway remodeling in nonsmokers with allergic asthma and in those with nonallergic asthma. On HRCT scans, the authors observed emphysema, cylindrical and varicose bronchiectasis, bronchial wall thickening (ie, bronchial recruitment), and linear opacities (“sequellar line shadows”). The findings were significantly more prevalent in individuals with nonallergic asthma than in individuals with allergic asthma. Scores of the findings were significantly greater in both groups and were associated with the severity and duration of asthma. ^[49] Centrilobular emphysema was most severe in individuals with severe nonallergic asthma and was not observed in control subjects without asthma.

Whether true emphysema exists in patients with asthma or whether only terminal airspace enlargement is involved in bronchial asthma. ^[50] the severity of the findings appears to be correlated with the clinical measures of severe asthma. Paganin et al suggested that some form of airway remodeling accounted for the findings and that the process likely differed in allergic asthma versus nonallergic asthma. An interesting speculation is that interstitial emphysema and peribronchial fibrosis may be the result of rupture of the dilated bronchial glands that are present in bronchial asthma. ^[51]

Confirming earlier findings, authors from Japan also showed that smokers with moderately severe asthma have a significantly higher emphysema score (13.7% vs 2.3%) than that of nonsmokers. As expected, the diffusion capacity was correlated with the emphysema score and the pack-years of cigarette smoking. The authors concluded that, in smokers with asthma, emphysema develops independent of the asthmatic condition. ^[52] Determining the difference between the 2 conditions may illuminate variations in the decline of lung function and the prognosis.

The 10-year mortality rate in patients with an emphysematous form of COPD (ie, 60%) is substantially worse than that of atopic control subjects or nonsmokers with known asthma (15%). ^{[53, 54]} Therefore, differentiating between the 2 groups is important from an imaging point of view.

Findings of a later study confirmed that a subgroup of individuals with asthma who also had emphysema tended to smoke more than others and that they have poorer lung function. ^[55] In this study, the patients with asthma were selected from a group with suspected allergic bronchopulmonary aspergillosis (ABPA) who actually did not have ABPA, cystic fibrosis, bronchiectasis, or immune deficiency, as prior laboratory and HRCT findings revealed.

In another study, a group of individuals with reversible asthma were stratified in terms of absent, mild, or severe emphysema. Neither the duration nor the severity of asthma was correlated with the presence of emphysema, whereas smoking history, sex, and age were strongly correlated. Patients with long-standing and partially reversible bronchial asthma did not have emphysema if they were nonsmokers. ^[56] The findings also were consistent with the observation that DLCO typically is preserved in nonsmokers with asthma.

The correlation of airtrapping with pulmonary function was studied by using HRCT in 74 patients with chronic airway disease, including asthma, ^[57] and it was found that on expiratory HRCT scans, the airtrapping and expired volume scores were inversely correlated with FEV1, FEV1/FVC, and FEF25. The TLC was not correlated with any of the imaging, age, sex, cigarette smoking history, or visual HRCT scores. Airtrapping was found, even when PFT results were normal; this finding suggests a complementary role for HRCT in the functional evaluation of asthma. HRCT may be more sensitive than PFT or DLCO alone in the evaluation of centrilobular and panlobular emphysema. ^[51]

By the late 1980s, the HRCT features that were accepted as demonstrating emphysema included low-attenuating regions, pulmonary vascular pruning, distortion, disruption, and bullae. The use of an attenuation mask allowed the semiautomated measurement of hypoattenuation in focal regions of the lungs, with quantification in regions of interest, in which other findings then were correlated. ^[58]

Gevenois et al demonstrated that the distribution of lung attenuation, as visualized on CT scans, depends on the TLC and, to a lesser degree, age. ^[59] However, Biernacki et al showed a considerable overlap in lung attenuation, as measured in Hounsfield units, in the evaluation of patients with chronic asthma, patients with chronic bronchitis and emphysema, and control subjects without asthma. The authors confirmed a correlation (r = 0.63) between TLC and the index of lung attenuation, although neither lung attenuation nor TLC changed after PEFR improved with the use of a nebulized adrenergic bronchodilator. ^[60]

Ng et al investigated airtrapping as an expression of small airway narrowing. The authors examined 106 patients with small airway disease and 19 healthy individuals. They found that decreased attenuation was more prominent on expiratory HRCT scans than on inspiratory HRCT scans. ^[61]

Quantitative CT analysis also has promise. Newman et al demonstrated that patients with asthma could be distinguished from individuals without asthma by using machine calculations of the percentage of lung area near the diaphragm with an attenuation less than –900 HU at end expiration. ^[62] This finding was true for both standard CT and HRCT, and it was correlated with the degree of airtrapping, as measured with the FRC and RV. A report of expiratory HRCT findings of airtrapping included inspiratory scans that had normal findings and suggested that the most common underlying causes of airtrapping were asthma and bronchiolitis obliterans. ^[63]

Additional methods have emerged with the development of dynamic HRCT scanning. With these methods, anatomic variations in bronchial obstruction can be studied after a provocative challenge. For example, the temporal development of airtrapping can be demonstrated with the successive, rapid acquisition of CT images during expiration. ^[64] .

Dynamic CT scans demonstrate that the increase in attenuation in the dependent and basilar portions of the lungs in individuals without asthma is greater than that of individuals with asthma. ^[65] Nevertheless, images in 4 of 10 individuals without asthma also showed airtrapping during rapid exhalation. Clinically, the usefulness of this modality is yet to be determined.

Studies of HRCT images in asthma consistently reveal the presence of bronchiectasis in patients with asthma but not ABPA. In ABPA, bronchiectasis often is considered part of the definition of the disease. Dilated airways may take the form of cylindrical, varicose, or cystic bronchiectasis. Park et al observed bronchial dilatation in 31% of patients with asthma versus 7% of control subjects. The authors measured bronchoarterial ratios but did not find a statistically significant difference between the groups. ^[66]

Lynch et al showed that dilated bronchi, defined as bronchi that are larger than accompanying arteries in which the tapering pattern is not lost, were observed in 59% of the control subjects compared with 77% of the patients with asthma. Other researchers found no or few such features in control subjects. A decreased arterial diameter with hypoventilation and hypoxic vasoconstriction, a sectioning artifact near the branching arteries and bronchi, a bronchodilator effect on medium-sized airways, and subclinical ABPA are potential explanations for the unexpectedly high percentage of findings in control subjects. The authors discussed CT scanner gantry tilting, as used in HRCT examination of patients with bronchiectasis. ^[67] They outlined their ability to follow the natural branching pattern of the bronchi in their plane. ^[55]

The reported prevalence of dilated, normally tapering bronchi ranged from 18% with skin test results that were positive for Aspergillus species, which are common in patients with mild asthma, to almost 80% in patients with moderately severe asthma. The varicose type, observed in as many as 60% of patients, was considered to be more specific for nonallergic asthma and severe asthma, whereas the cylindrical type occurred in both allergic asthma and nonallergic asthma with varying degrees of severity. ^[49]

In a study by Grenier et al, subsegmental and distal bronchiectasis was more common in patients with asthma (29%) than in healthy volunteers (7%). The changes were considered permanent, especially if they were varicose or cystic; the prevalence of these changes and the number of involved lobes increased with disease severity. The authors studied interobserver variability and found that interobserver and intraobserver agreement (k = 0.40) were clinically acceptable for bronchial wall thickening, bronchial dilatation, small centrilobular opacities, and decreased lung attenuation. Interobserver and intraobserver agreement was not clinically acceptable with subtypes of bronchiectasis, such as the cylindrical and varicose subtypes. ^[68]

Investigators in early studies used HRCT findings to prove that bronchial dilatation was prevalent in 41% of the pulmonary lobes in 8 patients with asthma who had clinical and immunologic evidence of ABPA and in 15% of lobes studied in 8 patients with asthma who had positive skin test results for only Aspergillus fumigatus. ^[35] The authors speculated that the unexpected findings in individuals with asthma alone may have been due to steroidal suppression of immunologic markers in these patients who actually had ABPA, non-Aspergillus fungal disease, or cylindrical bronchiectasis.

Although upper lobe involvement and bronchial wall thickening were considered nonspecific findings, Neeld et al raised the awareness that asthma may be more destructive than previously thought. Also, central bronchiectasis in its various forms primarily may reflect the duration of an inflammatory airway process rather than determine the difference between ABPA and asthma per se. ^[35]

Compared with the value of the traditional modality of bronchography, the value of thoracic HRCT in demonstrating central bronchiectasis in ABPA was proven in all 21 patients with the disease and in most of the segments. Central and peripheral bronchiectasis, but not peripheral bronchiectasis alone, have been evaluated by using both chest radiography and HRCT images as a diagnostic criteria for ABPA. Angus et al observed bronchial dilatation in 82% of their 17 patients and in 41% of the affected lobes in patients with ABPA versus 18% and 5%, respectively, in patients with asthma and in those without ABPA. However, peripheral bronchiectasis alone was not found in any of the patients with ABPA. ^[69]

Mucoid impaction is a well-defined finding in patients with ABPA. It may appear as centrilobular bronchiolar plugging or have a tree-in-bud appearance on HRCT scans. Mucoid impaction is believed to be one of the physiologic origins of mosaic lung attenuation. ^[12] Paganin et al attributed the development of varying degrees of cylindrical bronchiectasis to sequela of multifocal mucoid impactions and bronchial hypersecretion in asthma ^[49]

Grenier et al found a 21% incidence of centrilobular opacities on HRCT scans obtained in patients with asthma, compared with 5% in individuals without asthma. The authors believed that these opacities and the decreased lung attenuation can be related to the severity of asthma. The authors studied intraobserver and interobserver variability and found that, with bronchial wall thickening, bronchial dilatation, small centrilobular opacities, and decreased lung attenuation, intraobserver (k = 0.60-0.79) and interobserver (k = 0.40-0.64) agreement was clinically acceptable. ^[68]

Carroll et al found that, in cartilaginous airways, the total areas of the inner wall and outer wall, smooth muscle, mucous gland, and cartilage were greater in fatal cases of asthma than in control and nonfatal cases. ^[70] The internal size of segmental to sixth-generation bronchi was studied in healthy control subjects by using HRCT. Measurements ranged from 0.8-8 mm in diameter, with the use of 2-HU windows, 5X optical magnification, and automated luminal area calculation. The authors used a 2-HU window to clarify the edges of the bronchial walls to enhance the reproducibility of the measurement. ^[71]

Hudon et al used HRCT to show that bronchial thickening in patients with asthma and irreversible airflow obstruction was significantly greater (2.4 mm) than that of patients with completely reversible asthma (2 mm) despite the similar internal diameters of their airways. ^[72]

Lynch et al observed bronchial wall thickening on CXRs and HRCT scans in 71% and 92% of individuals with asthma, respectively (vs HRCT in 19% of control subjects). The authors’ patient selection was somewhat biased toward those with asthma complications and smokers (44%). ^[55] As discussed before, a decreased arterial diameter with hypoventilation and hypoxic vasoconstriction, a sectioning artifact near branching arteries and bronchi, a bronchodilator effect on medium airways, and subclinical ABPA were considered to be potential explanations for the unexpectedly high percentage of findings in control subjects.

Park et al found bronchial wall thickening proportional to severity in 44% of stable nonsmokers with asthma versus 4% of control subjects. Bronchial wall thickening occurred in 83% of patients with severe airflow obstruction versus 35% in patients with mild obstruction and 38% in control subjects. ^[66]

Grenier et al found bronchial wall thickening in 82% of patients with asthma versus 7% of control subjects; this finding established one of the largest differentials between these groups, although the measurements were solely subjective. Nevertheless, the method of measurement appeared to be reliable in terms of intraobserver and interobserver variability. ^[68] Others had similar findings. ^{[69, 73, 49, 74]}

In an autopsy study of individuals who died with asthma as well as those who died from asthma, large airway and small airway thickening was observed in individuals with lethal asthma, whereas small airway thickening was observed only in nonlethal asthma. ^[70]

Awadh et al studied airway wall thickening and found no significant difference in the ratio of wall thickness to outer diameter or the percentage of wall area to the total outside cross-section in patients with near-lethal asthmatic attacks versus patients with moderate asthma. ^[75] Both groups differed from patients with mild asthma and from individuals without asthma. Nevertheless, even the group with mild asthma differed from individuals without asthma; this finding confirming those of others and demonstrating that individuals with mild asthma can have airway thickening if the condition is chronic. The findings were present in both the small airways (< 2 mm) and the larger airways (>2 mm). The findings support the concept of chronic airway thickening in asthma and the likelihood of airway remodeling; interstitial peribronchial fibrosis; and, perhaps, parabronchial inflammation, which may cause accompanying centrilobular emphysema.

Okazawa et al evaluated a known feature in patients with asthma, that is, the exaggerated airway response to bronchoconstricting stimuli. Patients with mild-to-moderate asthma and control subjects received a methacholine challenge, and airway lumen narrowing was normalized for FRC. In both groups, the site similar (small, < 2 mm; medium, >2 mm) and extent of airway luminal narrowing on HRCT scans were similar, as were the reductions in FEV1 values. Only patients with asthma had extensive small airway wall thickening without an increased airway wall area; this finding did not change much after a bronchoconstrictor was administered. Control subjects did not have wall thickening, and their airway wall area decreased. The authors concluded that nonreversible small airway wall thickening in patients with asthma contributed to an exaggerated response of the small airways to stimuli. ^[76]

In the intermediate bronchi of individuals with asthma and fixed or partly reversible obstruction, Boulet et al observed no difference in bronchial wall thickness relative to the diameter compared with that of control subjects. Small airways, in which asthma and COPD cause substantial pathophysiologic changes, were not studied. The authors suggested that mechanical properties of the airway wall were probably more important than wall thickness in determining airway responsiveness. ^[77]

In another study of bronchoeffector agents, the appearance of the airways on HRCT scans showed that airway internal luminal diameter slightly decreased in individuals with mild asthma and that specific airway resistance increased after methacholine administration; this effect completely reversed after the bronchodilator agent albuterol was administered, and an improvement compared with baseline values was even observed. Airway wall thickness did not change in terms of the diameter, and pulmonary functions did not change with treatment. The investigators were able to quantify the changes in patients with asthma and control subjects by using HRCT scans. ^[78]

In attempting to differentiate COPD from asthma with HRCT scans, Park et al showed that bronchial walls were thicker in bronchial asthma (2.3 mm thicker than normal) than in COPD (0.9 mm thicker than normal). However, the ratio of wall thickness to luminal diameter was not correlated with clinical features such as smoking history, duration of symptoms, physiologic measures (eg, FEV1), specific airway conductance, and a provocative concentration of the bronchoconstrictor methacholine. HRCT findings of tubular bronchiectasis, emphysema, and mosaic lung attenuation were correlated with a long history of asthma symptoms, compromised lung function, and decreased bronchial hyper responsiveness. ^[66] The authors concluded that differentiating COPD from asthma is possible from the data, although the usefulness of the data in individual cases remains speculative.

Carr et al studied the role of the small airways in severe asthma by using HRCT. Inspiratory and expiratory scans were obtained with an electron-beam scanner. The mean decrease in the expiratory-to-inspiratory cross-sectional area was measured: Findings were 76% in patients versus 45% in control subjects. The results showed marked initial inspiratory airway narrowing, and further narrowing with expiration in patients with asthma was limited. The authors also found that FEV1 was correlated with this narrowing and with CT features of airtrapping, but not with features of airway wall thickening or airway dilatation. Airtrapping was observed with and without overt bronchiectasis in some lung regions; this finding led to the speculation that small airway disease with airtrapping may precede bronchiectasis. As previously shown, FEV1 and RV are correlated with end-expiratory airtrapping in individuals with asthma. ^[79]

Guckel et al also evaluated the source of mosaic attenuation on HRCT scans and observed the influence of oxygen administration on this appearance. In 22 patients with asthma who received a methacholine challenge, high-flow oxygen administered by face mask at a rate of 12 L/min produced the greatest increase in volume-corrected attenuation in regions of mosaic attenuation, compared with the nasal administration of oxygen at a rate of 5 L/min or the use of room air. The proposed and plausible explanation is that hypoxic vasoconstriction, another known cause of mosaic attenuation (airtrapping) besides bronchial narrowing, may account for foci of decreased attenuation in patients with asthma. ^[80]

In addition, airtrapping is observed in some areas of bronchiectasis in individuals with asthma due to weakness of the bronchiolar walls and resultant airway collapse during exhalation. ^[81] Ng et al investigated airtrapping as an expression of small airway narrowing on HRCT scans. The authors examined 106 patients with small airway disease and 19 healthy individuals. They found that decreased attenuation was more prominent on expiratory HRCT scans than on inspiratory HRCT scans. ^[61]

Paganin et al found both reversible and irreversible findings on HRCT scans of individuals with asthma. Mucoid impaction, acinar opacities, and lobar collapse resolved within 2 weeks of treatment with oral steroids. Bronchiectasis, bronchial wall thickening, linear opacities, and emphysema were unchanged during that interval and were considered permanent. While chest radiographs alone showed abnormal findings in 38% of patients, CT demonstrated abnormal findings in 72% of patients, and the authors concluded that patients with more severe asthma are more likely to have irreversible abnormalities. ^[73]

Grenier et al also studied the effect of treatment in patients with asthma without ABPA who had more mucoid impaction or lobar collapse on HRCT scans than on chest radiographs alone. The features tended to resolve with use of corticosteroids. ^[68]

Another study of bronchoeffector agents and the appearance of airways on HRCT scans revealed that airway internal luminal diameter slightly decreased and specific airway resistance increased after the administration of methacholine in patients with mild asthma. These effects completely reversed after the bronchodilator agent albuterol was administered, and an improvement compared with baseline values was even observed. Airway wall thickness did not change with treatment in these patients or in the control subjects. In the control subjects, neither airway luminal diameter nor pulmonary function changed. HRCT scans significantly aid in quantifying the changes in patients with asthma and in control subjects. ^[78]

Goldin et al examined 15 patients with asthma and 8 control subjects by using spirometry and HRCT and by using a methacholine challenge and albuterol inhalant reversal (see the images below). The authors showed a shift in the frequency distribution curve of lung attenuation and small airway cross-sectional area after bronchoprovocation; the findings reversed after bronchodilators were administered. The findings were correlated with changes in FEV1 in individuals with asthma and with a lack of changes in control subjects. ^[82]

Aside from cardiovascular applications, MRI of the thorax is used primarily as a problem-solving modality in the workup of patients with lung, mediastinal, or pleural lesions. MRI is a useful alternative to CT pulmonary angiography in evaluating possible pulmonary embolic disease in patients in whom iodinated contrast agent cannot be administered and when the avoidance of ionizing radiation is preferred. In bronchial asthma, the most promising work appears to involve the use of special paramagnetic gases, which amplify the low signal-to-noise ratio of conventional spin-echo and gradient-echo techniques by several thousand times. The use of such gases offsets the disadvantages of the large magnetic susceptibility states with consequent shortened T2* signals induced by the air-alveolar interfaces.

Using hyperpolarized helium (³He) produced as needed in a local laser laboratory, de Lange and colleagues performed 32 MRI examinations with a 2-dimensional fast low-angle shot (FLASH) sequence and an interleaved echo-planar sequence immediately after the patient inhaled 1-2 L of freshly prepared gas. The imaging required short-to-intermediate breath holds (approximately 5-22 s), a set of Helmholtz coils centered over the anterior and posterior thorax, and a special radiofrequency receiver tuned to the 48-MHz Larmor frequency of³ He gas. The gas is prepared with an optical pumping technique by which energy is transferred by laser to a small quantity of a rubidium agent, which, in turn, conveys it to low-energy-state dipoles of the resident³ He. In healthy individuals, ³He gas is transferred immediately and completely to the most peripheral airways and airspaces because of its high intrinsic diffusibility. ^{[83, 84]}

When ventilation defects are observed, healthy areas continue to have a homogeneous distribution. One patient in the de Lange study had a history of asthma and normal findings with initial testing. One week later, when the patient had mild seasonal allergies, repeat examination revealed 2 new, discrete, peripheral ventilation defects when the patient had a new onset of allergic symptoms. The findings subsequently resolved on MRIs obtained 1 week later and after treatment. ^[85]

A later study demonstrated similar reversibility in patients receiving the bronchodilator albuterol(see the images below). ^[86] The proposed mechanism of action is mucous plugging or bronchospasm, although peripheral defects alone are not believed to be unique to asthma, and they also reflect small airway processes such as emphysema, bronchiolitis, and cystic fibrosis.

In comparison to the results of nuclear medicine ventilation lung scanning with xenon-133 gas, the resolution of ventilation defects on MRIs is substantially superior. Interobserver variability is yet to be tested on a larger scale, but it appeared to be acceptable in the group studied. ^[85] . ^[86] Problems related to the availability of the fundamental gas are yet to be overcome, but they may be solved by hyperpolarizing the gas and making slight modifications to the MRI unit.

Additional studies have been performed by using hyperpolarized xenon-129 gas. Oxygen has significant paramagnetic properties and, when used in a 100% concentration, it obviates the use of specialized materials and equipment that is required in ³He hyperpolarized gas. The use of oxygen requires specialization of the pulse sequences, but it is highly diffusible, cheap, and available, and oxygen can be used readily without modifications to the basic MRI unit.

A study by Tahir et al compared lobar lung ventilation computed from expiratory and inspiratory CT data with direct measurements of ventilation at ³He MR imaging by using same-breath hydrogen 1 (¹H) MR imaging examinations. According to the authors, percentage of regional ventilation per lobe calculated at CT was comparable to a direct measurement of lung ventilation at ³He MR imaging, providing evidence for the validity of the CT model, and same-breath ¹H MR imaging enabled regional interpretation of ³He ventilation MR imaging of the underlying lung anatomy on thin-section CT. ^[87]

A study by Hahn et al quantified the redistribution of ventilation-weighted signal in the lungs of asthmatics during a breath-hold using high temporal-spatial resolution ³He MRI. The 39 study subjects were classified as healthy/nondiseased (N=14), mild-to-moderate asthma (N=17), or severe asthma (N=8).  Mild to moderate asthmatics showed the greatest rate of signal change, even though severe asthmatics had the greatest end-inspiration ventilation heterogeneity. According to the authors, the observed results support the existence of local differences in airway resistances associated with the different obstructive patterns in the lungs for severe versus mild-to-moderate asthmatics. ^[88]

Svenningsen et al used temporal and spatial information available via ³He MRI to generate pulmonary ventilation temporal-spatial maps to measure, optimize, and guide asthma therapy. The maps identified temporally persistent and intermittent ventilation defects. Intermittent ventilation defect percent was significantly greater in the posterior and inferior lung, as compared to the anterior and superior lung. Persistent and intermittent ventilation defect percent were strongly correlated with forced expiratory volume in 1 second/forced vital capacity. ^[89]

In animal and human studies, Chen et al have shown the effectiveness of centrically reordered single-shot rapid acquisition with relaxation enhancement, a short effective echo time, and short interecho spacing. ^{[90, 91]} Oxygen-enhanced MRI techniques also show great promise in functional imaging of the airways. ^{[92, 93]}

Generally, the use of ultrasonography in chest imaging is limited to the evaluation of mediastinal masses or pleural disease, with or without procedural localization. In airway diseases, the numerous reflective interfaces of the air spaces severely limit the acquisition of diagnostic information. Sonography does not provide truly reproducible images of specific airways that are useful in diagnosis or in monitoring treatment responses. One study of paranasal A-mode ultrasonography compared with radiography recognized the need to screen patients with asthma for correlative sinus disease. The authors found no reliable relationship between use of A-mode ultrasonography and the standard use of plain radiography. ^[94]

Nuclear medicine technology has been used in the study of aerosol and particulate distribution in the airways. Technetium-99m DTPA radioaerosol lung scintigraphy is a classic technique that shows the extent of major airway distribution, peripheral distribution (depending on particle size), and absorption in the oronasal air passages. Time-activity curves of the radioaerosol have been generated as an index of bronchoalveolar epithelial permeability in asthmatic and nonasthmatic house painters occupationally exposed to isocyanates and have shown a positive correlation between the rate of clearance and work duration. ^[95]

Technetium-99m radioaerosol has been used to show improved peripheral lung distribution of corticosteroid both in normal subjects and in persons treating their asthma using dry-powder inhalers as opposed to pressurized metered-dose inhalers (pMDIs) with a spacer device. One study has shown improved peripheral deposition of inhaled corticosteroid and several measures of lung function after 1 week of pretreatment with a bronchodilator. However, another study showed no significant change in peripheral radioaerosol distribution after 2 months of pMDI administration of corticosteroid with a spacer, despite improvements in FVC and a serum marker of asthmatic inflammation. The authors concluded that improvements in airway function due to aerosolized corticosteroids could occur despite the lack of change in lung deposition. ^{[96, 97, 98, 99]}

Ventilation scanning with ^99mTc DTPA has also been used as an indicator of ventilation defects in asthmatic children, demonstrating an improvement in homogeneity in distribution of radioaerosol after inhaled steroid therapy. Decreased oral deposition has also been shown with spacer devices and has been linked to a lower prevalence of oral candidiasis and systemic absorption. ^{[100, 101]}

The formulation of nonchlorofluorocarbon propellants—namely hydrofluoroalkane (HFA)—has allowed the production of substantially smaller particle size (mass median aerodynamic diameter of 1.2 micrometers rather than the 3.8-micrometer size of the chlorofluorocarbon formulation). This has allowed better drug deposition to the small airways, less oropharyngeal deposition, a low risk of systemic absorption, and small improvements in secondary efficacy measures (eg, as-needed albuterol use, asthma symptoms). Because studies have shown that the inflammatory response in the distal lung in asthma can exceed that in the large airways, the new HFA-based corticosteroids have the potential to treat asthma more effectively and at reduced steroid doses. ^[102]

In children given a beclomethasone dipropionate/HFA formulation, lung deposition increased with age among groups aged 5-7 years, 8-10 years, and 11-14 years and positively correlated with FEV1 and FVC. The gastrointestinal dose correlated negatively with age, height, and extent of obstructive disease in these subjects. An argument has been put forward that given the difficulty in conducting direct measurements of the clinical responses to inhaled asthma drugs, lung deposition data could be used as a surrogate for the clinical response to new agents. Such data could help save significant time in the drug development process. ^{[103, 104]}

While conventional lung scintigraphy has involved the process of physically associating pharmaceuticals in a nebulizer, pMDI, or dry powder form, the physical dissociation of the drug from radioaerosol has limited investigations of drug kinetics. Positron emitters such as carbon-11 and fluorine-18 can be directly incorporated into the drug formulations and then evaluated using positron emission tomography (PET) technology. Not only are 3-dimensional and higher-resolution images possible, but now evaluations of drug uptake and metabolism are possible. ^[105]

Berridge has (1) demonstrated that central airway (ie, tracheal and major bronchial) deposition of triamcinolone aerosol is demonstrated much better by PET than would have been expected with standard ^99mTc planar imaging; (2) demonstrated that a rapid fall-off occurs in the drug formulation due to mucociliary clearance; and (3) estimated that despite the fall-off of radiotracer in the peripheral lung, the therapeutic effects likely relate to the presumably steroid-receptor–rich target. Once again, improved peripheral deposition and reduced oropharyngeal deposition were proven with a spacer device used in drug delivery. ^[106]

Another use of PET has been in the differentiation of COPD from asthma. Jones et al used 18-fluorodeoxyglucose and carbon-11 PK11195 to show that in situ neutrophil uptake of 18-fluorodeoxyglucose was greater in COPD patients than in normal subjects or those with asthma. Mean uptake of carbon-11 PK11195 into macrophages was mostly greater in both the COPD and asthmatic patients than in control subjects in this pilot study. ^[107]

Swain DG. Pneumothorax in acute asthma. Br Med J (Clin Res Ed). 1984 Jul 14. 289(6437):109. [Medline].

Spottswood SE, Liaw K, Hernanz-Schulman M, Hilmes MA, Moore PE, Patterson B, et al. The clinical impact of the radiology report in wheezing and nonwheezing febrile children: a survey of clinicians. Pediatr Radiol. 2009 Apr. 39(4):348-53. [Medline].

Halaby C, Feuerman M, Barlev D, Pirzada M. Chest radiography in supporting the diagnosis of asthma in children with persistent cough. Postgrad Med. 2014 Mar. 126 (2):117-22. [Medline].

Woods AQ, Lynch DA. Asthma: an imaging update. Radiol Clin North Am. 2009 Mar. 47(2):317-29. [Medline].

Kim YW, Han SK, Shim YS, et al. The first report of diffuse panbronchiolitis in Korea: five case reports. Intern Med. 1992 May. 31(5):695-701. [Medline].

Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA. 1994 Feb 2. 271(5):363-7. [Medline].

Rossi OV, Lahde S, Laitinen J, Huhti E. Contribution of chest and paranasal sinus radiographs to the management of acute asthma. Int Arch Allergy Immunol. 1994 Sep. 105(1):96-100. [Medline].

Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med. 1989 Oct. 149(10):2277-82. [Medline].

Shapiro GG, Christie DL. Gastroesophageal reflux and asthma. Clin Rev Allergy. 1983 Mar. 1(1):39-56. [Medline].

Cuevas Hernández MM, Arias Hernández RM. [Pulmonary gammagraphy study in asthmatic children with gastroesophageal reflux]. Rev Alerg Mex. 2008 Nov-Dec. 55(6):229-33. [Medline].

Gay BB Jr. Radiologic evaluation of the nontraumatized child with respiratory distress. Radiol Clin North Am. 1978 Apr. 16(1):91-112. [Medline].

Webb WR. Radiology of obstructive pulmonary disease. AJR Am J Roentgenol. 1997 Sep. 169(3):637-47. [Medline].

Sutherland GR, Hume R, Davison M, Kennedy J. The use of pulmonary x-ray densitometry in evaluating regional bronchospasm in patients with bronchial asthma. Br J Radiol. 1972 Jun. 45(534):432-6. [Medline].

Blackie SP, al-Majed S, Staples CA, et al. Changes in total lung capacity during acute spontaneous asthma. Am Rev Respir Dis. 1990 Jul. 142(1):79-83. [Medline].

Salam H, Warwick WJ. Measurement of total lung capacity by a roentgenography-planimetry method in children 4-16 years of age. Respiration. 1978. 36(4):177-82. [Medline].

Pappas GP, Brodkin CA, Sheppard L, et al. The validity of radiographic estimation of total lung capacity in patients with respiratory disease. Chest. 1998 Aug. 114(2):513-20. [Medline].

Hungerford GD, Williams HB, Gandevia B. Bronchial walls in the radiological diagnosis of asthma. Br J Radiol. 1977 Nov. 50(599):783-7. [Medline].

Alford BA, Armstrong P. Radiographic evaluation of the child who wheezes. Curr Probl Diagn Radiol. 1983 May-Jun. 12(3):1-38. [Medline].

Gillies JD, Reed MH, Simons FE. Radiologic assessment of severity of acute asthma in children. J Can Assoc Radiol. 1980 Mar. 31(1):45-7. [Medline].

Joorabchi B, Hammoude E, Khalid MA. Radiographic inversion of pulmonary blood flow in acute asthma. Clin Pediatr (Phila). 1994 May. 33(5):286-91. [Medline].

Hodson ME, Simon G, Batten JC. Radiology of uncomplicated asthma. Thorax. 1974 May. 29(3):296-303. [Medline].

Findley LJ, Sahn SA. The value of chest roentgenograms in acute asthma in adults. Chest. 1981 Nov. 80(5):535-6. [Medline].

Brenner BE. Bronchial asthma in adults: presentation to the emergency department. Part I: Pathogenesis, clinical manifestations, diagnostic evaluation, and differential diagnosis. Am J Emerg Med. 1983 Jul. 1(1):50-70. [Medline].

Gershel JC, Goldman HS, Stein RE, et al. The usefulness of chest radiographs in first asthma attacks. N Engl J Med. 1983 Aug 11. 309(6):336-9. [Medline].

Heckerling PS. The need for chest roentgenograms in adults with acute respiratory illness. Clinical predictors. Arch Intern Med. 1986 Jul. 146(7):1321-4. [Medline].

Buenger RE. Five thousand acute care/emergency department chest radiographs: comparison of requisitions with radiographic findings. J Emerg Med. 1988 May-Jun. 6(3):197-202. [Medline].

Aronson S, Gennis P, Kelly D, et al. The value of routine admission chest radiographs in adult asthmatics. Ann Emerg Med. 1989 Nov. 18(11):1206-8. [Medline].

Sherman S, Skoney JA, Ravikrishnan KP. Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease. Diagnostic value. Arch Intern Med. 1989 Nov. 149(11):2493-6. [Medline].

White CS, Cole RP, Lubetsky HW, Austin JH. Acute asthma. Admission chest radiography in hospitalized adult patients. Chest. 1991 Jul. 100(1):14-6. [Medline].

Dalton AM. A review of radiological abnormalities in 135 patients presenting with acute asthma. Arch Emerg Med. 1991 Mar. 8(1):36-40. [Medline].

Rubenstein HS, Rosner BA, LeMay M, Neidorf R. The value of the chest X-ray in making the diagnosis of bronchial asthma. Adolescence. 1993 Fall. 28(111):505-16. [Medline].

Tsai TW, Gallagher EJ, Lombardi G, et al. Guidelines for the selective ordering of admission chest radiography in adult obstructive airway disease. Ann Emerg Med. 1993 Dec. 22(12):1854-8. [Medline].

Roback MG, Dreitlein DA. Chest radiograph in the evaluation of first time wheezing episodes: review of current clinical practice and efficacy. Pediatr Emerg Care. 1998 Jun. 14(3):181-4. [Medline].

Rencken I, Patton WL, Brasch RC. Airway obstruction in pediatric patients. From croup to BOOP. Radiol Clin North Am. 1998 Jan. 36(1):175-87. [Medline].

Neeld DA, Goodman LR, Gurney JW, et al. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1990 Nov. 142(5):1200-5. [Medline].

Standertskjold-Nordenstam CG, Halttunen PA, Meurala HG. Cinetracheobronchography and surgical correction of central airway collapse in an asthmatic patient. Eur J Radiol. 1981 Mar. 1(1):20-3. [Medline].

Kessler GF, Austin JH, Graf PD, et al. Airway constriction in experimental asthma in dogs: tantalum bronchographic studies. J Appl Physiol. 1973 Nov. 35(5):703-8. [Medline].

Forbes AR, Gamsu G. Lung mucociliary clearance after anesthesia with spontaneous and controlled ventilation. Am Rev Respir Dis. 1979 Oct. 120(4):857-62. [Medline].

Teel GS, Engeler CE, Tashijian JH, duCret RP. Imaging of small airways disease. Radiographics. 1996 Jan. 16(1):27-41. [Medline].

Montaudon M, Lederlin M, Reich S, Begueret H, Tunon-de-Lara JM, Marthan R, et al. Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings. Radiology. 2009 Dec. 253(3):844-53. [Medline].

Ohno Y, Koyama H, Matsumoto K, Onishi Y, Nogami M, Takenaka D, et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol. 2011 Jan. 77(1):85-91. [Medline].

King GG, Muller NL, Pare PD. Evaluation of airways in obstructive pulmonary disease using high- resolution computed tomography. Am J Respir Crit Care Med. 1999 Mar. 159(3):992-1004. [Medline].

McNamara AE, Muller NL, Okazawa M, et al. Airway narrowing in excised canine lungs measured by high-resolution computed tomography. J Appl Physiol. 1992 Jul. 73(1):307-16. [Medline].

Herold CJ, Brown RH, Mitzner W, et al. Assessment of pulmonary airway reactivity with high-resolution CT. Radiology. 1991 Nov. 181(2):369-74. [Medline].

Brown RH, Herold C, Zerhouni EA, Mitzner W. Spontaneous airways constrict during breath holding studied by high- resolution computed tomography. Chest. 1994 Sep. 106(3):920-4. [Medline].

Brown RH, Mitzner W, Wagner EM. Interaction between airway edema and lung inflation on responsiveness of individual airways in vivo. J Appl Physiol. 1997 Aug. 83(2):366-70. [Medline].

Brown RH, Herold CJ, Hirshman CA, et al. In vivo measurements of airway reactivity using high-resolution computed tomography. Am Rev Respir Dis. 1991 Jul. 144(1):208-12. [Medline].

Kinsella M, Muller NL, Staples C, et al. Hyperinflation in asthma and emphysema. Assessment by pulmonary function testing and computed tomography. Chest. 1988 Aug. 94(2):286-9. [Medline].

Paganin F, Seneterre E, Chanez P, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med. 1996 Jan. 153(1):110-4. [Medline].

Snider GL. Distinguishing among asthma, chronic bronchitis, and emphysema. Chest. 1985 Jan. 87(1 Suppl):35S-39S. [Medline].

Paganin F, Jaffuel D, Bousquet J. Significance of emphysema observed on computed tomography scan in asthma. Eur Respir J. 1997 Nov. 10(11):2446-8. [Medline].

Kondoh Y, Taniguchi H, Yokoyama S, et al. Emphysematous change in chronic asthma in relation to cigarette smoking. Assessment by computed tomography. Chest. 1990 Apr. 97(4):845-9. [Medline].

Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 Nov 19. 317(21):1309-14. [Medline].

Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 Nov 19. 317(21):1309-14. [Medline].

Lynch DA, Newell JD, Tschomper BA, et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology. 1993 Sep. 188(3):829-33. [Medline].

Mochizuki T, Nakajima H, Kokubu F, et al. Evaluation of emphysema in patients with reversible airway obstruction using high-resolution CT. Chest. 1997 Dec. 112(6):1522-6. [Medline].

Lucidarme O, Coche E, Cluzel P, et al. Expiratory CT scans for chronic airway disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 1998 Feb. 170(2):301-7. [Medline].

Muller NL, Staples CA, Miller RR, Abboud RT. “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest. 1988 Oct. 94(4):782-7. [Medline].

Gevenois PA, Scillia P, de Maertelaer V, et al. The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. AJR Am J Roentgenol. 1996 Nov. 167(5):1169-73. [Medline].

Biernacki W, Redpath AT, Best JJ, MacNee W. Measurement of CT lung density in patients with chronic asthma. Eur Respir J. 1997 Nov. 10(11):2455-9. [Medline].

Ng CS, Desai SR, Rubens MB, et al. Visual quantitation and observer variation of signs of small airways disease at inspiratory and expiratory CT. J Thorac Imaging. 1999 Oct. 14(4):279-85. [Medline].

Newman KB, Lynch DA, Newman LS, et al. Quantitative computed tomography detects air trapping due to asthma. Chest. 1994 Jul. 106(1):105-9. [Medline].

Arakawa H, Webb WR. Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: correlation with pulmonary function tests and differential diagnosis. AJR Am J Roentgenol. 1998 May. 170(5):1349-53. [Medline].

Paganin F, Chanez P, Seneterre E, et al. Value of imaging in asthma. Rev Pneumol Clin. 1996. 52(2):88-96. [Medline].

Webb WR, Stern EJ, Kanth N, et al. Dynamic pulmonary CT: findings in healthy adult men. Radiology. 1993 Jan. 186(1):117-24. [Medline].

Park JW, Hong YK, Kim CW, et al. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol. 1997 May-Jun. 7(3):186-92. [Medline].

Remy-Jardin M, Remy J. Comparison of vertical and oblique CT in evaluation of bronchial tree. J Comput Assist Tomogr. 1988 Nov-Dec. 12(6):956-62. [Medline].

Grenier P, Mourey-Gerosa I, Benali K, et al. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol. 1996. 6(2):199-206. [Medline].

Angus RM, Davies ML, Cowan MD, et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax. 1994 Jun. 49(6):586-9. [Medline].

Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis. 1993 Feb. 147(2):405-10. [Medline].

Seneterre E, Paganin F, Bruel JM, et al. Measurement of the internal size of bronchi using high resolution computed tomography (HRCT). Eur Respir J. 1994 Mar. 7(3):596-600. [Medline].

Hudon C, Turcotte H, Laviolette M, et al. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol. 1997 Feb. 78(2):195-202. [Medline].

Paganin F, Trussard V, Seneterre E, et al. Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis. 1992 Oct. 146(4):1084-7. [Medline].

Webb WR. High-resolution computed tomography of obstructive lung disease. Radiol Clin North Am. 1994 Jul. 32(4):745-57. [Medline].

Awadh N, Muller NL, Park CS, et al. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax. 1998 Apr. 53(4):248-53. [Medline].

Okazawa M, Muller N, McNamara AE, et al. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med. 1996 Nov. 154(5):1557-62. [Medline].

Boulet L, Belanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med. 1995 Sep. 152(3):865-71. [Medline].

Kee ST, Fahy JV, Chen DR, Gamsu G. High-resolution computed tomography of airway changes after induced bronchoconstriction and bronchodilation in asthmatic volunteers. Acad Radiol. 1996 May. 3(5):389-94. [Medline].

Carr DH, Hibon S, Rubens M, et al. Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma. Respir Med. 1998 Mar. 92(3):448-53. [Medline].

Guckel C, Wells AU, Taylor DA, et al. Mechanism of mosaic attenuation of the lungs on computed tomography in induced bronchospasm. J Appl Physiol. 1999 Feb. 86(2):701-8. [Medline].

Stern EJ, Frank MS. Small-airway diseases of the lungs: findings at expiratory CT. AJR Am J Roentgenol. 1994 Jul. 163(1):37-41. [Medline].

Goldin JG, McNitt-Gray MF, Sorenson SM, et al. Airway hyperreactivity: assessment with helical thin-section CT. Radiology. 1998 Aug. 208(2):321-9. [Medline].

de Lange EE, Altes TA, Patrie JT, Battiston JJ, Juersivich AP, Mugler JP 3rd, et al. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology. 2009 Feb. 250(2):567-75. [Medline].

Tustison NJ, Altes TA, Song G, de Lange EE, Mugler JP 3rd, Gee JC. Feature analysis of hyperpolarized helium-3 pulmonary MRI: a study of asthmatics versus nonasthmatics. Magn Reson Med. 2010 Jun. 63(6):1448-55. [Medline].

de Lange EE, Mugler JP III, Brookeman JR, et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology. 1999 Mar. 210(3):851-7. [Medline].

Altes TA, Powers PL, Knight-Scott J, et al. Hyperpolarized (3)He MR lung ventilation imaging in asthmatics: Preliminary findings. J Magn Reson Imaging. 2001 Mar. 13(3):378-84. [Medline].

Tahir BA, Van Holsbeke C, Ireland RH, Swift AJ, Horn FC, Marshall H, et al. Comparison of CT-based Lobar Ventilation with (3)He MR Imaging Ventilation Measurements. Radiology. 2016 Feb. 278 (2):585-92. [Medline].

Hahn AD, Cadman RV, Sorkness RL, Jarjour NN, Nagle SK, Fain SB. Redistribution of inhaled hyperpolarized He3 gas during breath-hold differs by asthma severity. J Appl Physiol (1985). 2015 Dec 3. jap.00197.2015. [Medline].

Svenningsen S, Guo F, Kirby M, Choy S, Wheatley A, McCormack DG, et al. Pulmonary functional magnetic resonance imaging: asthma temporal-spatial maps. Acad Radiol. 2014 Nov. 21 (11):1402-10. [Medline].

Chen Q, Jakob PM, Griswold MA, et al. Oxygen enhanced MR ventilation imaging of the lung. MAGMA. 1998 Dec. 7(3):153-61. [Medline].

Ohno Y, Chen Q, Hatabu H. Oxygen-enhanced magnetic resonance ventilation imaging of lung. Eur J Radiol. 2001 Mar. 37(3):164-71. [Medline].

Jung JW, Kwon JW, Kim TW, Lee SH, Kim KM, Kang HR, et al. New insight into the assessment of asthma using xenon ventilation computed tomography. Ann Allergy Asthma Immunol. 2013 Aug. 111(2):90-95.e2. [Medline].

Kirby M, Coxson HO, Parraga G. Pulmonary Functional Magnetic Resonance Imaging for Paediatric Lung Disease. Paediatr Respir Rev. 2013 Mar 20. [Medline].

Pfister R, Lutolf M, Schapowal A, et al. Screening for sinus disease in patients with asthma: a computed tomography-controlled comparison of A-mode ultrasonography and standard radiography. J Allergy Clin Immunol. 1994 Nov. 94(5):804-9. [Medline].

Kaya M, Salan A, Tabakoglu E, Aydogdu N, Berkarda S. The bronchoalveolar epithelial permeability in house painters as determined by Tc-99m DTPA aerosol scintigraphy. Ann Nucl Med. 2003 Jun. 17(4):305-8. [Medline].

Hirst RH, Newman SR, Clark DA, Hertog MG. Lung deposition of budesonide from the novel dry powder inhaler Airmax. Respir Med. 2002 Jun. 96(6):389-96. [Medline].

Hirst PH, Pitcairn GR, Weers JG, Tarara TE, Clark AR, Dellamary LA, et al. In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler. Pharm Res. 2002 Mar. 19(3):258-64. [Medline].

Newman SP, Pitcairn GR, Adkin DA, Vidgren MT, Silvasti M. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer. J Aerosol Med. 2001 Summer. 14(2):217-25. [Medline].

Saari SM, Vidgren MT, Herrala J, Turjanmaa VM, Koskinen MO, Nieminen MM. Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids. Respir Med. 2002 Dec. 96(12):999-1005. [Medline].

Yüksel H, Yüksel D, Demir E, Tanaç R, Kayaliodlu M. Effect of inhaled steroid therapy on distribution of Tc-99m DTPA radioaerosol in asthmatic children. Allergy Asthma Proc. 2000 Nov-Dec. 21(6):361-5. [Medline].

Corren J, Tashkin DP. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma. Clin Ther. 2003 Mar. 25(3):776-98. [Medline].

Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol. 2002 Feb. 109(2 Suppl):S447-60. [Medline].

Devadason SG, Huang T, Walker S, Troedson R, Le Souëf PN. Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children. Eur Respir J. 2003 Jun. 21(6):1007-11. [Medline].

Newman SP. Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?. Br J Clin Pharmacol. 2000 Jun. 49(6):529-37. [Medline].

Dolovich MB. Measuring total and regional lung deposition using inhaled radiotracers. J Aerosol Med. 2001. 14 Suppl 1:S35-44. [Medline].

Berridge MS, Lee Z, Heald DL. Pulmonary distribution and kinetics of inhaled [11C]triamcinolone acetonide. J Nucl Med. 2000 Oct. 41(10):1603-11. [Medline].

Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J. 2003 Apr. 21(4):567-73. [Medline].

Acimovic S, Plavec G, Tomic I, Karlicic V, Acimovic S, Vukovic J, et al. [Symptoms, physical findings and bronchial hypersensitivity in patients with bronchial asthma and normal spirometry]. Vojnosanit Pregl. 2009 Jan. 66(1):39-43. [Medline].

Adams NP, Bestall JC, Jones P, Lasserson TJ, Griffiths B, Cates CJ. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev. 2008 Oct 8. CD003534. [Medline].

ALA Denver. Resolving the riddle: does chronic infection lead to chronic asthma?In: Denver 2000 Asthma Research Center Progress Report. Available at: http://www.lungusa.org/arc/index1.html#denver. Accessed November 7, 2001.

ALA Facts. Facts about asthma. In: Asthma Research Centers 2000 Progress Report. Available at: http://www.lungusa.org/arc/index.html#facts. Accessed November 7, 2001.

ALA Utah. Deconstructing asthma to unravel Its genetic basis. In: Utah 2000 Asthma Research Center Progress Report. Available at: http://www.lungusa.org/arc/index2.html#utah. Accessed November 7, 2001.

Beales JS, Saxton HM. The radiographic demonstration of bronchospasm and its relief by aminophylline. Br J Radiol. 1968 Dec. 41(492):899-901. [Medline].

Bevelaqua F, Schicchi JS, Haas F, et al. Aortic arch anomaly presenting as exercise-induced asthma. Am Rev Respir Dis. 1989 Sep. 140(3):805-8. [Medline].

BMJ. Editorial: chest radiographs in asthma. Br Med J. 1974 Oct 19. 4(5937):123-4. [Medline].

Boulet LP, Turcotte H, Hudon C, et al. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD. Can Respir J. 1998 Jul-Aug. 5(4):270-7. [Medline].

Braman SS, Davis SM. Wheezing in the elderly. Asthma and other causes. Clin Geriatr Med. 1986 May. 2(2):269-83. [Medline].

Brown RH, Zerhouni EA, Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol. 1995 Oct. 79(4):1242-8. [Medline].

Brown RH, Zerhouni EA, Mitzner W. Visualization of airway obstruction in vivo during pulmonary vascular engorgement and edema. J Appl Physiol. 1995 Mar. 78(3):1070-8. [Medline].

Busse WW, Holgate ST. Epidemiology of asthma. In: Asthma and Rhinitis. Blackwell Science Inc. 1995:15-31.

Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY, et al. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med. 2008 Nov 15. 178(10):1002-8. [Medline].

Caramella D, Bulleri A, Battolla L, et al. Spontaneous epidural emphysema and pneumomediastinum during an asthmatic attack in a child. Pediatr Radiol. 1997 Dec. 27(12):929-31. [Medline].

Castro-Rodriguez JA, Holberg CJ, Wright AL, et al. Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med. 1999 Jun. 159(6):1891-7. [Medline].

Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009 Mar. 123(3):e519-25. [Medline].

Cates CJ, Cates MJ, Lasserson TJ. Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2008 Oct 8. CD006923. [Medline].

Cates CJ, Lasserson TJ. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev. 2009 Jan 21. CD007085. [Medline].

Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol. 1998 Jan. 28(1):23-9. [Medline].

Charpin J, Gayrard P. [Localization of airway obstruction demonstrated by dynamic bronchography]. Bronches. 1974 Sep-Oct. 24(5):240-51. [Medline].

Clinton JE, Yaron M, Tsai SH. Chest radiography in the emergency department. Ann Emerg Med. 1986 Mar. 15(3):254-6. [Medline].

Collard P, Njinou B, Nejadnik B, et al. Single breath diffusing capacity for carbon monoxide in stable asthma. Chest. 1994 May. 105(5):1426-9. [Medline].

Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol. 2009 Jan. 102(1):22-8. [Medline].

Cozanitis DA, Halttunen P, Edgren J. A cinebronchographic study demonstrating the effect of galanthamine hydrobromide on conscious asthmatic volunteers. Anaesthesist. 1972 Feb. 21(2):63-6. [Medline].

Cullinan P, Hayes J, Cannon J, et al. Occupational asthma in radiographers. Lancet. 1992 Dec 12. 340(8833):1477. [Medline].

Dijkman JH, Vooren PH, Kramps JA. Occupational asthma due to inhalation of chloramine-T. I. Clinical observations and inhalation-provocation studies. Int Arch Allergy Appl Immunol. 1981. 64(4):422-7. [Medline].

Gannon PF, Bright P, Campbell M, et al. Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departments. Thorax. 1995 Feb. 50(2):156-9. [Medline].

Gerald LB, McClure LA, Mangan JM, Harrington KF, Gibson L, Erwin S, et al. Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school-based supervised asthma therapy. Pediatrics. 2009 Feb. 123(2):466-74. [Medline].

Gershel J. Criteria for deciding when to obtain chest radiographs in first time wheezers. Pediatr Emerg Care. 1998 Dec. 14(6):452. [Medline].

Gettler JF. Acute asthma. Utility of admission chest radiography. Chest. 1992 Jun. 101(6):1744. [Medline].

Gillies DR, Conway SP, Littlewood JM. Chest X-rays and childhood asthma. Lancet. 1983 Nov 12. 2(8359):1149. [Medline].

Giudicelli R, Dupin B, Surpas P, et al. Gastroesophageal reflux and respiratory manifestations: diagnostic approach, therapeutic indications and results. Ann Chir. 1990. 44(7):552-4. [Medline].

Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982 Jul. 33(4):379-87. [Medline].

Gordon SB, Curran AD, Fishwick D, et al. Respiratory symptoms among glass bottle workers–cough and airways irritancy syndrome?. Occup Med (Lond). 1998 Oct. 48(7):455-9. [Medline].

Gourdon C, Dietemann A, Beigelman C, et al. Recurrent interlobar pneumothorax in an asthmatic patient. Eur Respir J. 1993 May. 6(5):748-9. [Medline].

Hartman TE, Primack SL, Lee KS, et al. CT of bronchial and bronchiolar diseases. Radiographics. 1994 Sep. 14(5):991-1003. [Medline].

Hatch RT, Parker JM, Engler RJ. Wheezing, hypoxia, and dyspnea in a 62-year-old woman. Ann Allergy. 1993 May. 70(5):363-7. [Medline].

Holden DA, Mehta AC. Evaluation of wheezing in the nonasthmatic patient. Cleve Clin J Med. 1990 Jun. 57(4):345-52. [Medline].

Hurwitz S, Conlan AA. A tracheal tumor simulating asthma in a child. Heart Lung. 1981 Sep-Oct. 10(5):880-2. [Medline].

Ikeda K, Tanno N, Tamura G, et al. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol. 1999 Apr. 108(4):355-9. [Medline].

Ikeda Y, Yamashita H, Tamura T. Diffuse pulmonary ossification and recurrent spontaneous pneumothorax in a patient with bronchial asthma. Respir Med. 1998 Jun. 92(6):887-9. [Medline].

Isselbacher KJ. Heart failure. In: Braunwald E, Wilson JD, et al, eds. Harrison’s Principles of Internal Medicine. 13th ed. McGraw-Hill. 1994:1001.

Jaeschke R, O’Byrne PM, Mejza F, Nair P, Lesniak W, Brozek J, et al. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med. 2008 Nov 15. 178(10):1009-16. [Medline].

Jamadar DA, Kazerooni EA, Hirschl RB. Pneumomediastinum: elucidation of the anatomic pathway by liquid ventilation. J Comput Assist Tomogr. 1996 Mar-Apr. 20(2):309-11. [Medline].

Janahi I, Fan LL. Bronchogenic cyst masquerading as asthma. J Pediatr. 1998 Jul. 133(1):166. [Medline].

Jones DK, Cavanagh P, Shneerson JM, et al. Does bronchography have a role in the assessment of patients with haemoptysis?. Thorax. 1985 Sep. 40(9):668-70. [Medline].

Kelly MA, Joos TH. All that wheezes is not asthma: the pediatric radiologist saves the day. J Asthma. 1992. 29(1):55-6. [Medline].

Khanijo V, Del Giacco DR, Poggi JA, et al. Left mainstem bronchus narrowing in an asthmatic patient. Chest. 1982 May. 81(5):635-6. [Medline].

Koinis-Mitchell D, McQuaid EL, Seifer R, Kopel SJ, Nassau JH, Klein RB, et al. Symptom perception in children with asthma: Cognitive and psychological factors. Health Psychol. 2009 Mar. 28(2):226-37. [Medline].

Kuhn JP. High-resolution computed tomography of pediatric pulmonary parenchymal disorders. Radiol Clin North Am. 1993 May. 31(3):533-51. [Medline].

Lillington GA, Muller NL. Radiological imaging in the detection and differentiation of diffuse obstructive airway diseases. Clin Rev Allergy. 1990 Summer-Fall. 8(2-3):277-90. [Medline].

Lucidarme O, Grenier P, Coche E, et al. Bronchiectasis: comparative assessment with thin-section CT and helical CT. Radiology. 1996 Sep. 200(3):673-9. [Medline].

Lynch DA. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol Clin North Am. 1998 Jan. 36(1):129-42. [Medline].

Mahabee-Gittens EM, Bachman DT, Shapiro ED, Dowd MD. Chest radiographs in the pediatric emergency department for children < or = 18 months of age with wheezing. Clin Pediatr (Phila). 1999 Jul. 38(7):395-9. [Medline].

Marmorstein BL, Cianciulli FD. Planimetric measurement of total lung capacity in asthma. Chest. 1974 Oct. 66(4):378-81. [Medline].

Mayo JR. MR imaging of pulmonary parenchyma. Magn Reson Imaging Clin N Am. 2000 Feb. 8(1):105-23. [Medline].

Mclean AN, Sproule MW, Cowan MD, et al. High resolution computed tomography in asthma. Thorax. 1998 Apr. 53(4):308-14. [Medline].

Meneghello A, Molfese G, Rampazzo F, et al. [Thickening of the bronchial wall in asthma and asthma-like bronchitis]. Minerva Med. 1986 Jan 28. 77(3-4):109-12. [Medline].

Milne EN, Bass H. The roentgenologic diagnosis of early chronic obstructive pulmonary disease. J Can Assoc Radiol. 1969 Mar. 20(1):3-15. [Medline].

Mitchell TA, Hamilos DL, Lynch DA, Newell JD. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma. 2000 Feb. 37(1):65-72. [Medline].

Montiel Trujillo A, Ruiz Ruiz M, Jimenez Navarro M, et al. [Pneumopericardium in an asthmatic patient. A case report and review of the bibliography]. Rev Esp Cardiol. 1999 Nov. 52(11):1015-8. [Medline].

Murata T, Imamura M, Taniguchi M, et al. Localization of the bronchodilatory effects of isoproterenol and aminophylline in patients with bronchial asthma: an investigation using selective alveolobronchography. J Int Med Res. 1997 Nov-Dec. 25(6):325-39. [Medline].

Murray JF, Nadel JA. Structure of the lungs relative to their principal function. In: Textbook of Respiratory Medicine. WB Saunders Co. 1988:15-20.

Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009 Mar 5. 360(10):985-93. [Medline].

Nastasi KJ, Howard DA, Raby RB, et al. Airway fluoroscopic diagnosis of vocal cord dysfunction syndrome. Ann Allergy Asthma Immunol. 1997 Jun. 78(6):586-8. [Medline].

Nuhoglu Y, Bahceciler N, Yuksel M, et al. Thorax high resolution computerized tomography findings in asthmatic children with unusual clinical manifestations. Ann Allergy Asthma Immunol. 1999 Mar. 82(3):311-4. [Medline].

O”Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000 Aug. 55(8):635-42. [Medline].

O”Hagan AR, Stillwell PC, Arroliga A. Airway responsiveness to inhaled albuterol in patients with pulmonary hypertension. Clin Pediatr (Phila). 1999 Jan. 38(1):27-33. [Medline].

Ohno Y, Koyama H, Matsumoto K, Onishi Y, Nogami M, Takenaka D, et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol. 2011 Jan. 77(1):85-91. [Medline].

Olazabal F Jr, Roman-Irizarry LA, Oms JD, et al. Pulmonary emboli masquerading as asthma. N Engl J Med. 1968 May 2. 278(18):999-1001. [Medline].

Panchal N, Pant C, Bhagat R, Shah A. Central bronchiectasis in allergic bronchopulmonary aspergillosis: comparative evaluation of computed tomography of the thorax with bronchography. Eur Respir J. 1994 Jul. 7(7):1290-3. [Medline].

Park SS, Shin DH, Lee DH, et al. Tracheopathia osteoplastica simulating asthmatic symptoms. Diagnosis by bronchoscopy and computerized tomography. Respiration. 1995. 62(1):43-5. [Medline].

Pifferi M, Marrazzini G, Baldini G, et al. Epidural emphysema in children with asthma. Pediatr Pulmonol. 1997 Aug. 24(2):125-6. [Medline].

Reinoso MA, Jett JR, Beck KC. Body plethysmography in the evaluation of intrathoracic airway abnormalities. Chest. 1992 Jun. 101(6):1674-6. [Medline].

Reittner P, Muller NL. Tracheal hamartoma: CT findings in two patients. J Comput Assist Tomogr. 1999 Nov-Dec. 23(6):957-8. [Medline].

Roach PJ, Treves ST. The value of bronchodilator administration in asthmatic patients before lung imaging. Clin Nucl Med. 1995 Jun. 20(6):491-3. [Medline].

Robards VL Jr, Lubin EN, Medlock TR, et al. Renal transplantation and placement of ileal stoma. Urology. 1975 Jun. 5(6):787-9. [Medline].

Robinson AE. Dimensional response of large airways during bronchography in the pediatric patient. Invest Radiol. 1973 May-Jun. 8(3):121-5. [Medline].

Robinson AE, Campbell JB. Bronchography in childhood asthma. Am J Roentgenol Radium Ther Nucl Med. 1972 Nov. 116(3):559-66. [Medline].

Rodrigo C, Rodrigo G. Subarachnoid hemorrhage following permissive hypercapnia in a patient with severe acute asthma. Am J Emerg Med. 1999 Nov. 17(7):697-9. [Medline].

Rolfe LM, Rayner CF. A wheezy man with a bony abnormality. Postgrad Med J. 1999 Aug. 75(886):503-4. [Medline].

Sasaki H, Okayama H, Aikawa T, et al. Central and peripheral airways as determinants of ventilatory function in patients with chronic bronchitis, emphysema, and bronchial asthma. Am Rev Respir Dis. 1986 Dec. 134(6):1182-9. [Medline].

Shao W, Chung T, Berdon WE, et al. Fluoroscopic diagnosis of laryngeal asthma (paradoxical vocal cord motion). AJR Am J Roentgenol. 1995 Nov. 165(5):1229-31. [Medline].

Shirakawa T, Takenaka S, Matsumoto T, et al. [A case of leiomyoma of the trachea]. Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Nov. 29(11):1464-8. [Medline].

Smedley J, Inskip H, Wield G, et al. Work related respiratory symptoms in radiographers. Occup Environ Med. 1996 Jul. 53(7):450-4. [Medline].

Spence DP, Kelly YJ, Ahmed J, et al. Critical evaluation of computerised x ray planimetry for the measurement of lung volumes. Thorax. 1995 Apr. 50(4):383-6. [Medline].

Spivey CG Jr, Walsh RE, Perez-Guerra F, et al. Central airway obstruction. Report of seven cases. JAMA. 1973 Dec 3. 226(10):1186-9. [Medline].

Stern EJ, Song JK, Frank MS. CT of the lungs in patients with pulmonary emphysema. Semin Ultrasound CT MR. 1995 Oct. 16(5):345-52. [Medline].

Strunk RC, Bacharier LB, Phillips BR, Szefler SJ, Zeiger RS, Chinchilli VM, et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol. 2008 Dec. 122(6):1138-1144.e4. [Medline].

Tarlo SM, Broder I, Prokipchuk EJ, et al. Association between celiac disease and lung disease. Chest. 1981 Dec. 80(6):715-8. [Medline].

Toral Marin J, del Castillo Otero D, Hurtado Ayuso JE, Calderon Osuna E. [Spontaneous pneumomediastinum as a complication of asthmatic crisis]. Rev Clin Esp. 1999 Feb. 199(2):78-80. [Medline].

Trigg CJ, Heap DC, Herdman MJ, et al. A radiographer”s asthma. Respir Med. 1992 Mar. 86(2):167-9. [Medline].

Tsuji H, Takazakura E, Terada Y, et al. CT demonstration of spinal epidural emphysema complicating bronchial asthma and violent coughing. J Comput Assist Tomogr. 1989 Jan-Feb. 13(1):38-9. [Medline].

Tucker GF Jr. Pulmonary migraine. Ann Otol Rhinol Laryngol. 1977 Sep-Oct. 86(5 Pt 1):671-6. [Medline].

US Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Asthma Prevalence, Health Care Use and Mortality:United States, 2003-05. CDC National Center for Health Statistics. Available at http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ashtma03-05/asthma03-05.htm. Accessed: May 1, 2009.

van der Klooster JM, Grootendorst AF, Ophof PJ, et al. Pneumomediastinum: an unusual complication of bronchial asthma in a young man. Neth J Med. 1998 Apr. 52(4):150-4. [Medline].

Woolcock AJ, McRae J, Morris JG, Read J. Abnormal pulmonary blood flow distibution in bronchial asthma. Australas Ann Med. 1966 Aug. 15(3):196-203. [Medline].

World Health Organization Media Centre. Asthma: Key Facts. World Health Organization. Available at http://www.who.int/mediacentre/factsheets/fs307/en/index.html. Accessed: May 1, 2009.

Lars J Grimm, MD, MHS Assistant Professor, Department of Diagnostic Radiology, Duke University Medical Center

Disclosure: Nothing to disclose.

Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

Eugene C Lin, MD Attending Radiologist, Teaching Coordinator for Cardiac Imaging, Radiology Residency Program, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine

Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging

Disclosure: Nothing to disclose.

Jeffrey A Miller, MD Associate Adjunct Professor of Clinical Radiology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School; Faculty, Department of Radiology, Veterans Affairs of New Jersey Health Care System

Jeffrey A Miller, MD is a member of the following medical societies: American Roentgen Ray Society, Radiology Alliance for Health Services Research, Society of Thoracic Radiology

Disclosure: Nothing to disclose.

Peter G Canaday, MD, FACR Consultant Radiologist, Taranaki District Health Board, New Zealand

Peter G Canaday, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Radiological Society of North America, Society of Breast Imaging, and Society of Thoracic Radiology

Disclosure: Nothing to disclose.

Jannette Collins, MD, MEd, FCCP Benjamin Felson Professor and Chair of Radiology, University of Cincinnati College of Medicine

Disclosure: Nothing to disclose.

Asthma Imaging

Research & References of Asthma Imaging|A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us